<SEC-DOCUMENT>0000849146-13-000042.txt : 20131031
<SEC-HEADER>0000849146-13-000042.hdr.sgml : 20131031
<ACCEPTANCE-DATETIME>20131031172048
ACCESSION NUMBER:		0000849146-13-000042
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20131031
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131031
DATE AS OF CHANGE:		20131031

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		131183678

	BUSINESS ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kfinalresultsofto.htm
<DESCRIPTION>TENDER OFFER RESULTS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2013 WebFilings LLC. All Rights Reserved -->
		<title>8-K: Final Results of TO</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s4E4CD7B7AA2EEAEF027F8521475FD24F"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:4px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________&#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">the Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): October 31, 2013</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:center;vertical-align:middle;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;text-align:center;vertical-align:middle;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center;vertical-align:middle;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;vertical-align:middle;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="32%"></td><td width="3%"></td><td width="31%"></td><td width="3%"></td><td width="31%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Colorado</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">(State or other Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">(Commission</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">(IRS Employer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9815 S. Monroe Street, Suite 100, Sandy, UT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">84070</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801)&#160;432-9000</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s06294D7C4D2336C051D18527660CC842"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12%"></td><td width="88%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;8.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Events</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 31, 2013, LifeVantage Corporation (the &#8220;Company&#8221;) issued a press release announcing the final results of its recently completed tender offer in which the Company offered to purchase for cash up to $40 million in value of shares of its common stock (the "Offer").  A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing summary of the Offer does not purport to be complete and is qualified in its entirety by reference to the Tender Offer Statement on Schedule TO filed on September 24, 2013, as amended, and such document is incorporated herein by reference.</font></div><a name="s29515CC860A5D74C55898527ABC4501B"></a><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12%"></td><td width="88%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibits</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="14%"></td><td width="2%"></td><td width="20%"></td><td width="64%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release issued by the Company on October 31, 2013.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s04A4CEB2F6A41B19CCAC852C958AA36D"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:32px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:624px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="312px"></td><td width="312px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: October 31, 2013</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION </font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:    </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Rob Cutler</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:   Rob Cutler</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:   General Counsel</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>prtenderofferfinalresult.htm
<DESCRIPTION>TENDER OFFER RESULTS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2013 WebFilings LLC. All Rights Reserved -->
		<title>PR:  Tender Offer Final Result</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s9B1D7A53FA089EDA35290A1E869CCCE7"></a><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:5pt;"><font style="font-family:inherit;font-size:5pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="tenderofferfinalresul_image1.jpg" style="height:41px;width:268px;"></div><div style="line-height:120%;padding-top:24px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">LifeVantage Corporation Announces Final</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Results&#160;of&#160;Self Tender&#160;Offer</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Salt Lake City, Utah</font><font style="font-family:inherit;font-size:12pt;">, October 31, 2013 &#8211; LifeVantage Corporation (Nasdaq: LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, today announced the final results of its modified Dutch auction tender offer for up to $40 million in value of its common stock, which expired at 5:00 p.m., New&#160;York City time, on Friday, October 25, 2013.  In accordance with the terms and conditions of the tender offer, the Company has accepted for purchase an aggregate of 16,326,530 shares of its common stock at a purchase price of $2.45 per share, for an aggregate cost of approximately $40 million.  These shares represent approximately 13.9% of the Company&#8217;s outstanding shares of common stock as of September 13, 2013.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The depositary informed the Company that 20,026,222 shares of the Company&#8217;s common stock were properly tendered and not properly withdrawn at the purchase price of $2.45 per share.  Because more than $40 million in value of common stock was properly tendered and not properly withdrawn, the tender offer was oversubscribed.  As a result, pursuant to the terms of the tender offer, shares will be accepted on a pro rata basis.  The final proration factor for the tender offer is approximately 81.53%.  The Company will promptly pay for the shares accepted for purchase, and any shares tendered and not purchased will be returned to tendering shareholders promptly thereafter.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">D.A. Davidson &amp; Co. was the dealer manager for the tender offer.  Georgeson Inc. was the information agent for the tender offer and Computershare was the depositary for the tender offer. All inquiries about the tender offer should be directed to Georgeson Inc. toll-free at (866)&#160;482&#8209;4931.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About LifeVantage Corporation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker of Protandim</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, the Nrf2 Synergizer</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;patented dietary supplement, TrueScience</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;Anti-Aging Cream and LifeVantage&#174; Canine Health, is a science based network marketing company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such </font></div><br><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="36%"></td><td width="28%"></td><td width="36%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s9B1D7A53FA089EDA35290A1E869CCCE7"></a><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">as &#8220;believe,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and LifeVantage&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on LifeVantage&#8217;s current expectations and beliefs concerning future events affecting LifeVantage and involve known and unknown risks and uncertainties that may cause LifeVantage&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in LifeVantage&#8217;s Annual Report on Form 10-K under the caption &#8220;Risk Factors,&#8221; and in other documents filed by LifeVantage from time to time with the SEC. LifeVantage cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to LifeVantage on the date hereof, and LifeVantage undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Investor Relations Contact</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cindy England (801) 432-9036</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Director of Investor Relations</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">-or-</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">John Mills (310) 954-1105</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Senior Managing Director, ICR, LLC</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"># # # </font></div><br><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="36%"></td><td width="28%"></td><td width="36%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tenderofferfinalresul_image1.jpg
<TEXT>
begin 644 tenderofferfinalresul_image1.jpg
M_]C_X``02D9)1@`!`0$`E@"6``#_X0!:17AI9@``34T`*@````@`!0,!``4`
M```!````2@,#``$````!`````%$0``$````!`0```%$1``0````!```7$5$2
M``0````!```7$0```````8:@``"QC__;`$,`"`8&!P8%"`<'!PD)"`H,%`T,
M"PL,&1(3#Q0=&A\>'1H<'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_;`$,!"0D)#`L,&`T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_``!$(`$\!]P,!(@`"$0$#$0'_
MQ``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#
M!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!
M`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<`
M`0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`
M$)`&2<`5E:Q<&;2KJ*UD83,AVE>/PS5G4'(1$'0\FL^MJ4=I'/6G=.!Q_A?7
M#I>JB&>1OLL_RL">%;L?Z&O0_M\/^U^5>>^)M#92]]:H6C/,J*/NGU'M5KPS
MX@2]C6QNI`+I!A&)_P!8/\:ZZ].-3]XCAPM2=']U+Y'<?;X?]K\J/M\/^U^5
M9E96MZW'HT"L8C+*_P!U,X&/4FN>-%2=D=<J[BKLZI+V%VQN(^HJQ7">'/%%
MOXA^T1+"T%S;XWQDY!!Z$&NRLG+VXSS@XJ*M+D-*5;G+-9-WXCTVRNGMIY76
M1/O`(3VS6M7FOB;_`)&*[^J_^@BM,)1C5FXR[&&/Q,\/34H=ST2TNHKVUCN(
M"3&XRI(Q4U97AO\`Y%ZS_P!T_P`S6K6%2*C-Q70ZJ4G.G&3ZI!1114&@445!
M>7"VEG-<,,B)"V/7`II-NR$VDKLBOM5LM-4&ZG5">B]6/X"H-.U^PU2=H;9G
M\Q5W89".*\ZDDN=2OB[;I;B9N!ZD]`/:NO\`#F@7NEZ@;BX\K:T17"MD@Y%=
M]7"TZ5/WG[QY-''5J]:T(^Z=31117GGKA1110`5FWWB#2-,NTM+[4;>WN'`*
MQRN%)!.!^M:5>=_%SP__`&CX>3584S<6!R^!R8CU_(X/YUI2C&<U&74RK3E"
MFY15['HE%<M\/_$'_"0^$[::1]UU;_N)_4LHX/XC!_.NIJ9Q<).+Z%PFIQ4E
MU"BBBI*&R2)#$\LKA(T4LS,<``=2:I:;K>EZSYG]FWT%UY6-_E-NVYZ9_(UQ
MWQ:\0?V7X:&FPOBXU`E#CJ(Q][\^!^)K5^'GA_\`X1_PG;QR)MNKG]_/QR"1
MP/P&!]<UM[)*ESOKL8>U;K>SCLEJ=71116)N%%%%`!1110`4444`%%%%`!7(
M>._&<O@^"RDBLDNOM+LI#2%=N`/8^M=?7E/QM_X\]&_ZZR_R6M\-!3JJ,MCG
MQ4Y0HN4=SU.&3S8(Y",;U#8],BGU!9_\>-O_`-<U_E4]8O<W6P4444AA1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%#4>L?XU1J]J/6/\`
M&LRYN8+.V>XN95BA099V/`KII_"CDJ_$R6N:UGP?;7K&>SE%G<DY']PG^A^E
M<EXD^(MY*6@T<&VASCSF&9&^G]W^=<K#I?B/4;B.]DM-2G0.&:616(QG.<FN
MRG1DM6['!5Q$;\J5ST0ZWXJ\/1[=3TEM1MD_Y>(&RP'N1U_$"KC>1XWT>.\L
MRUM-&QC:*<<J?0X_,'WJ/PSXC?4KJ;1+S<\HB+1R_P!Y>A!]QGK6MX?S']J@
M;[R.,_J/Z4G[J;M9HI6G97NF5?"WA4>'Y+JYEG6:YN,*=@(55'8>M=O8?\>Y
M_P!ZLRM.P_X]S_O5R5I.2NSMH1479%JO-?$W_(Q7?U7_`-!%>E5YKXF_Y&*[
M^J_^@BMLO_BOT.7-_P""O7]&=KX;_P"1>L_]T_S-:M97AO\`Y%ZS_P!T_P`S
M6K7)6_B2]6=^'_@P]%^05A>+G>/0F9'9&\Q>5.#UK=JIJ-[;:?:&>ZSY08#A
M<\GVHI-JHFE<,1%2I23=M-SC_!T\TFLNKS2./))PS$]Q6YXHU.WMM/ELI-_G
M7$9V87CKW-6M-UO3M1N3#:;O,"ECF/;Q61XQTZYN#'=QHIA@C/F$M@CGTKLN
MJF)3FN4\_E=+!R5*7-_6IS.CW<5CJUO<S`^7&23@9/0BN_TS7;/5I7BMO,W(
MNX[TQQ7G%K:RWMREO``9'.%!.*[+POHM]IEY/)=1JJO&%&'!YS6^-A3:YF_>
MZ')EE2LI*$5[K>NGD=16#J/BRPLG:*+=<RC@B,_*/Q_PK-\6ZXZN=-MG*\?O
MF!YY_A_QK%T?0+G5R74B*W4X,C#K[`=ZYZ.%@H>TK.R.O$XZHZGL<.KLU&\<
M7.[Y;*(+Z%SFKUEXTM96"7<#P9_C!W+_`(T]?!.G!,/-<LW]X,!^F*QM7\)S
MV$37%JYN(5&6!&&4>OO6B6#J/E6AC)YA27.]5\CNXI4FC62)U=&&593D&DG@
MCN;>2"9`\4JE'4]"",$5Y]X<UM],NUAD<FTE;#`G[A/\0_K7HM<>(H2HRL>E
MA,5'$POUZH\7\&SR>"?B1=^'KIR+6Z?RD+=">L;?B#C\:]HKRWXP:$YMK3Q#
M:@K-:L(IF7J%)RK?@W'XUW'A/7$\1>&K/401YCIMF`_AD'#?KS]"*TK_`+R$
M:J]'ZD8;]W.5%]-5Z&U1G`R:*X[XE>(/["\)S+$^VZO/W$6.H!'S-^`_4BN:
M$'.2BNIU5)J$7)]#A8,_$/XKM*?GTRR.1Z&-#Q_WTW/T->UUPGPJ\/\`]D>%
MEO)4Q<Z@1*<CD1_P#\LG\:I_$SQA<Z?Y7A_1V?\`M&[`\QH_O(IX"K_M-^@^
MM=55>UJJG#9:')1DJ-%U:F[U_P`D;'B/XCZ%X=E>W:1KN\7AH;?!VG_:;H/Y
MUR1^,&JW!+V?AHO".^]VX^H7%;G@_P"&6GZ1;QW>KQ)>ZDPW,L@W1Q'T`Z$^
MY_"N_5510J*%4<``8`J7*A#1+F\RE'$5-7+E\CS'3/C-82S"'5M-GLSG!>-O
M,`^HP"/UKH]%^(&EZ]XCDT>QBF<HK.MQQY;@8Y'.>_I6KK?AC2/$-NT6HV4<
MC$?+*!B1?HW6O*_`.FIHWQ8O=-CD:1+:.:-788)`(ZU:C1J0E**LTB)2KTIQ
MC)W39[6>!FN*TOXGZ#?PWLUP9+&.T*@FX(RY.>%`))/%=HWW3]*\!^'WA"U\
M4Z[>/?L3:69#-$IP9"Q.!GL.#FLZ%.$H2E/I8TQ%6I"<(T^MSL[KXQV;3&+2
M=&O+UAT).S/X`$U7_P"%LZM!^\N_"-S'#W;<XQ^:8KTJQTZRTRW6"QM(;>(#
M`6)`HJU2]I16T/Q'[*N]74_!''^'/B1H/B*9+99'M+Q^%AN,#<?16'!^G6NP
MKSSXB>!;"_T>YU>PMTM]0MD,S&(;1*HY(('?'(-:?PUU^?7_``G&]VY>YMG,
M$CGJ^`""??!'Y45*<'#VE/;J@IU9JI[*IOT?<9XH^(VG>%=6&G75G=2R&(2;
MHMN,'/J?:O,_'_CFQ\7P6,=G:W$)MG=F,NWG('3!/I7NEQIFGW<OFW-C;3R8
MQOEA5CCZD5Y9\8]/LK*TT@VEG;P%I)-QBB"YX7K@5MA94^>*2U,,9&K[.3<M
M.UB]!\9]&BMXXSIU\2B!3]SL/K7;^&/$=MXITC^T;6&6*/S&CVRXSD?0^]/M
M-#TAK.`G2K$DQJ23;IZ?2J7B;6['P7X;ENH;:%&+;8((U"!Y#[#MQD_2L9>S
MF^6G'7U.B'M*:YJDM/0MZ_XHTCPU;B74[H1LP^2)1ND?Z+_7I7`3_&62>8II
M6@2SJ#UDD.3_`,!4''YU4\'^";CQ?<-XE\42R31SMNBA)P91ZGT3T`_EU];M
M+*UL(%@L[:*WB48"1(%'Z5<E1I>ZUS/\#.+KUO>3Y5^)Y=!\998)@FJ^'Y85
M)ZI(0P_!@,_G6W<?%KP_&MH;9+BY-P<%54*T1R!A@3[]LUVMY8VFH6[07EM%
M<0L,%)4##]:\.^('A2P\,^(M.;3MZ0W;[O)8Y$9##H>N.>]725"K*W+9D5GB
M*,>;FNO0]YHH[5YU\2_&-QIB1:#I#-_:5V!O:/[T:DX`7_:8_E^5<E.FZDN5
M'95JQI0<I&QXD^(NA>')'MY)6NKQ>#!;X)4_[1Z#^?M7(_\`"X-3N"7L_#+/
M#V.]F_4+BMKP=\,;#28([S68DO-28;BLGS1Q'T`_B/N?PKT!45%"HH51P`!@
M"MW*A#1+F\SG4<14]YRY?(\QTSXS6,DXAU;3)[,YP7C;S`OU&`1^M=%H_P`0
M=+USQ*^C6,<TA"LRW`QY;@`'CG/?TK7UKPUI'B"W:'4;*.4D<2`8=?<-U%>4
M^!]+31?B[<Z;'(TD=LDJ*[#DC`ZU<8T:D9.*LTB)2KTIQC)W39[93))8X8FE
ME=4C099F.`!ZDT^O'/$NJZC\0O%?_"-:-*4TV!CYT@^ZVT_,[>H!X`[G].>E
M2=1]DMSIK5E36UV]D;^M?%_1;"9H-.@EU&0'&]#LCS[$\G\!6/\`\+>UA1YK
M^&&$/KN<<?7;BN[\.^"M%\-P*+6U22X`^>YE`:1C]>WT%=#6KJ4(Z*-_5F2I
MXB6LIV\DC@]!^*^A:O*MO=A].G8X'G$&,G_>'3\<5W8(8`@@@\@BN3\4?#[1
MO$=O(ZP):7V/DN(EQD_[0'WA^M<EX"\1:CX>\0-X.UXG`;9;.QSL;J%![JPZ
M?_7H=.%2+E2W704:M2G)0JZI[/\`S/6J***Y3L"BB@G`R>E`&5K=S#9V_P!H
MN'"11J2S'_/6O*;^XU/QGJHM[9"L"'*H3\L8_O,?7_(K;\1ZC<>+-;33;`YM
M(6.&['U<^WI_]>NAL[2R\/Z<(D#+&.9)-A)8^IQ7H4X^SBNYYM62J2=G[I2T
M/PAIFBA9?*6YO.\\JYP?]D=OYULWA_T*X)/2)OY4EM>6UXI:VN(Y0.NULD?A
M1>_\>%S_`-<F_E4W;EJ.T5'W3S?P;_R/1_Z])/YK7=D?8]>5^D=TNT_[P_S^
MM<)X-_Y'H_\`7K)_-:]&OK47=L8P=L@.Y&]&'2MJKM/7L84%>GIW+-:=A_Q[
MG_>K)A,C0H9E"R$?,`<\UK6'_'N?]ZN.KL=U'XBU7FOB;_D8KOZK_P"@BO2J
M\U\3?\C%=_5?_016^7_Q7Z')F_\`!7K^C.U\-_\`(O6?^Z?YFM6LKPW_`,B]
M9_[I_F:U:Y*W\27JSOP_\&'HOR"L#QA_R`&_ZZ)_.M^L#QA_R`&_ZZ)_.JP_
M\6/J1C/]WGZ,P/!?_(:D_P"N)_F*ZOQ#_P`B_>_]<S7*>"_^0U)_UQ/\Q75^
M(?\`D7[W_KF:ZL5_O*^1PX+_`'*7S_(X?PW_`,C#9_[Q_D:]*8A5+'H!DUYK
MX;_Y&&S_`-X_R->E,NY&4]QBEF'\1>@\H_@R]?T1Y+<3&YNY)I"<R.68_4UV
M=MXLT>TMH[>**Y6.-=H'EC_&N+EB,-P\4@(*.5;UX-=;#X+M9X4ECU"1D=0R
MD(.0:[,2J/*O:/0\[!/$<TG12;ZW+G_"::9_SSN?^^!_C1_PFFE_\\[G_OV/
M\:K?\(-!_P`_TO\`WP*/^$&@_P"?Z7_O@5R<N#[L]#FS'LOP_P`SE+][:2^F
M>T5E@=MRJPP1GM7H^A7#76B6DK'+&/:3[CC^E8?_``@T'_/]+_WP*Z'3;%=-
MT^*T5RXCS\Q&"<DG^M&+K4JE-1@[M!@,-7I592J*R8NI6$&JZ9<V%RN8;B,Q
MM^(Z_45Y/\,K^?P]XKU#PK?MM\QV\O/3S%]/]Y>?P%>Q5Y%\5]*FTO6=/\56
M&4D#JDC#M(O*$_4`C\!6.&:E>D^OYG7BDXVK+[/Y'KM>*^(';Q]\4H-)B8M8
M6;&-B#QM4YD;\3\OY5W6N>,X+?X>?V]:L!)=1!+=<])6XQ_P$Y_[YK%^$&@&
MTT>?6YU/GWK;8RW7RP>OXMG\A3HITH2J/?9>I-=JM.-);;OT/2$18XU1%"HH
M`4#H!7CW@J,>(_BMJVK7'SBU:1XP><'=L3\ES7L=>/?#I_[(^).MZ5<';)*9
M%3/<J^1_XZ2:5#X)M;V*Q/\`$II[7_X8]AHHHKE.P*\B\-?\EQUC_MM_[+7K
MM>1>&O\`DN.L?]MO_9:Z</\`#/T.3$_%3]3UQONGZ5Y+\&?^/_7OK'_-Z]:;
M[I^E>2_!G_C_`->^L?\`-Z*7\&I\OS"M_'I_/\CUNBBBN8ZS.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KN]?_Y%S4_^O27_`-`-<)\%?^1;U#_K[_\`
M9%KIA_N\O5')4_WF'HSTRO*?C;_QYZ-_UUE_DM>K5Y3\;?\`CST;_KK+_):,
M)_&B/&_P)?UU/3[/_CQM_P#KFO\`*O)_B>7UGQSH>@!B(CLR/>1\$_D*]8L_
M^/&W_P"N:_RKR?XBL=(^)>A:O)_J,1DG_<<[OT(IX7^+YZDXS^#Y75SUR&&.
MW@C@A0)%&H1%'0`#`%/I`0RAE(((R".]+7*=@5Y'\8?^0UX?^K?^A+7KE>1_
M&'_D->'_`*M_Z$M=.$_C+Y_D<F._@/Y?F>N=J\=\(1CQ'\7-5U2X^=;1I'C#
M<X(.Q/R'\J]B[5X]X`<:/\4=;TN<[6F,JIGN0^X?FN33P_P3MO86)_B4T]K_
M`/#'L-%%%<IV!7D6@_\`)=M4_P"VO_H*UZ[7D6@_\EVU3_MK_P"@K73A_AGZ
M')B?BI^IZ'XMU!]+\):I>1G$D=NVP^C'@'\S7GOPJU'0-$T2ZN+_`%2SM[VY
MFP5EE`8(HXZ^Y)KO?&]H]]X*U>",$N;=F`'?;\W]*\S^'G@KP]XJT.:>]^T?
M;()BCB.7:-I`*G&/K^5:4>3V$N;N9UW/ZQ'E73J>G?\`":^&/^@]I_\`W_6C
M_A-?#'_0>T__`+_K7/\`_"H/"W]V]_[_`/\`]:C_`(5!X6_NWO\`W_\`_K5G
MRX?NS7FQ/9'0?\)KX8_Z#VG_`/?]:\R^*FH:/?7.F:MH^I6T]["Q1_(D#,`/
MF4\>AS^==;_PJ#PM_=O?^_\`_P#6H_X5!X6_NWO_`($?_6K2E*A3ES)LRK0Q
M%6#@TCL]-NOMVEVEWT\^%)/^^@#_`%HI]G:QV-E!:0Y\J"-8TW')P!@45QNU
M]#N5[:D]<IXVUE[2R73K4DW5UP=O4)T_,]/SKIYYX[:WDGE;;'&I9CZ`5Q?A
MJVDUW7[G7KM?W<;XA4]`W;\A^IK:C%:U);+\SGQ$V[4H[R_+J7M(\/KH>EQ[
M@#=2\S-Z'LH]A5VMMT61"K#(-5#IRYXD('N*:JWUD#H\ND=CC-<\.M+F_P!)
M8V]^GS`1G:)/\#_.J&B>,$U:VNM-OP(=22)\#&!+@'.!V8=Q7H/]G#_GJ?\`
MOFO+?B3X5:QU6QURSSLFG6.XVC&U\\-^/0__`%ZZ*52-1\C?H<E>G.G%SBO4
MI^#?^1Z/_7K)_-:]/KS7P/%YWC\INQ_HDAZ>ZUZS_9P_YZG_`+YHQ$TIV8\+
M"3A=%"M2P!%MD]SD4Q-/0'+.6'IC%6P`H``P!TKDG--61VTZ;3NQ:\U\3?\`
M(Q7?U7_T$5Z57+:KX4FU'4YKM;M$60C"E"<8`%;X*I&G4;D[:'+F5&I6I*--
M7=RII/BNTT_2X+62WF9XQ@E<8//UJ[_PF]E_SZW'_CO^-4?^$'N/^?Z+_OV?
M\:/^$'N/^?Z+_OV?\:Z)+!R;;?YG'!YC&*BHZ+T-:Q\5VE_>Q6L=O,K2'`+8
MP./K1XP_Y`#?]=$_G532_"<VGZE#=-=QN(R25"$9XQ6SK>FOJNFFUCD6-BX;
M<PR.*YVZ,*T73>AUQ6(J8:<:J]YWL<EX+_Y#4G_7$_S%=;KPSH-[G_GD:S="
M\-SZ1?M<27$<BF,IA5([C_"MG4;5KW3I[96"M*A4,1P*>(JPE74HO306$HU(
M85PDM=3S[PW_`,C#9_[Q_D:]+KE-+\)W&GZG!=/=1.L9)*A3D\8KJZ6-J1J3
M3B[Z#RVC4I4FJBL[G$^+=&>.=M2@3,3_`.N`_A/K]#5'1/$DVE+Y$J&:USD*
M#\R?3_"O0R`RE6`((P0>]<SJ/@VVN':2RE^SL?X",I_]:M*.)IRA[.ML8XC!
M585?;89Z]BTOB[2&3<9I%/\`=,9S6/JOC%YD,6G(T0[RN.?P%5F\&:F&P)+8
MCUWG_"K]EX)`<-?7.Y1_!$,9_$U:CA*;YKW,Y5,PJKDY;>>W]?(V/#^L_P!K
MV9+QE9HL!R!\I]Q_A6O45O;0VD"PV\:QQKT514M>?4<7)N*LCUZ49Q@E-W85
ME^(M'BU_0+S3)<#SHR$8_P`+CE3^!Q6I14IM.Z+DE)69\RZ?::KJ^H67A-W=
M5CNW'E$?ZICPY_`*3^?K7TI:6L-C9PVEN@2&%!&BCL`,"L2S\)6EGXROO$28
M\RYB5`F/NM_&WX@+^OK70UTXFNJMK;?J<F$P[HIN6_Z=`KRGXF>'[W3=6@\8
MZ.")82IN-HSM*]'QZ8X->K4C*KJ590RL,$$9!%8TJCIRYD;UJ2JPY6<WX2\:
M:=XJLE,4BPWRK^^M6/S`]ROJOO\`G72UYMX@^$MK=71O=!NSIUQG=Y7/E@^J
MD<K^&:RET+XJV8\F'5/.C'`8W"M^KC-;.E2GK"5O)F"K5H:5(7\T>L7=Y;6%
MJ]S=SQP01C+22-@"O'_!5];ZG\8=2OK5B]O.LSQL1C(R.<59C^&?BC7ITE\3
M:Z?+!SL60RL/H.%'ZUO>%_AR_AGQ9)J<-XCV7EM''$02X!QC)Z=JN*I4X27-
M=M&<G6JSB^6R3^9WS?=/TKR7X,_\?^O?6/\`F]>M'D$5QG@7P5<^$KC49;B\
MAN!=[=HC4C;@MUS]:QISBJ4XO=V-ZL).M"2V5_R.THHHK`Z3.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KT/4K5KW2[NT5@K3PO&&/0%@1G]:YWP'X3N
M/".EW-I<74=PTLWF!HU(`&`,<_2MXSBJ,H]=#FG"3KQDMDF=77E/QM_X\]&_
MZZR_R6O5JX[Q]X-N?&$%C';W<5N;9W9C(I.[('I]*,-)0JJ4MAXJ$IT7&.YU
M5G_QXV__`%S7^5<W\0/"Q\4^'FB@`^W6Q\VW)_B..5_$?J!73P1F*WCC)R44
M+GZ"I*SC-PES1-9P4X<LNIYA\/?'L0MT\/:\YMKVV_=123?*'`X"-GHPZ<]?
MK7I_49%<EXK^'ND^*2;A@;2_QC[1$!\W^\/XOY^]<:G@WXB:$/)TG6A-;C[J
MB?`'_`7&!^%=$HTJKYHOE?9G+&5:BN64>9=T>OUXI\4M:T_5/$FE6]C<I.]J
MQ68H<JI++QGN>*N/X.^(NNCR=6UI8;<_>4S\'_@*#!_&IYO@R(OL1L=3'F1M
MNG>9#\YR,;0.@Z^M:48TJ4N:4KOR,Z\JU:'+&%EYGK':O*_B;X>O++4K?Q?I
M`836Y4W&P<KM^Z_N,<'VQ[UZI2,H92K`%2,$$=:Y*51TY<R.RM256'*SF?"/
MC;3O%5DFQTAOU7]]:L>0?5?5?\FNGKS?Q#\);.\NC>Z%='3;G.[R\'R\^HQR
MOX5E#0OBI9#R8-5$T8X#&X5OU<9K9TJ4]82MY,P5:M#2I"_FCU>ZNK>RMGN;
MJ:.&&,9:21@`!]:\?\(7]OJGQGOKZT<O;S+,T;$8R,`9JPGPU\4Z_.DGB;73
MY2G.P2&5A]!PHJIX,TV#1_C%=:=;;_(MTE1-YR<;1U-:TX0A"=I7=C&K4J3J
M0;C97^9[00&!!`((P0:\6N%N_A7XW:YCB>71+XD87^[G.W_>7MZCZU[5534M
M,LM7L9+*_MTGMY!\R,/U'H?>N:C5Y&U)73W.NO1=1)Q=FMANE:O8:U8I>:=<
MI/"XZJ>5/H1U!]C5VO)[WX4ZII=XUWX5UMX">D<CLC#VW+U_$5%_8_Q8<>2=
M2"ITW^?&/U`S6GL*<M8S5O,S6(J1TG!W\CTC7O$>F^&[!KK4;A4X^2('+R'T
M4=ZJ^$/%,7BS1S?1VTMNR.8W1^1G_9;N*XO2OA+/<WHOO%&JO>29R8HW8[O8
MNW./8`?6O3;6UM[&UCMK6%(8(EVI&@P%%145*,;1=WW+I2K3ES25EVZE:YUO
M3+.\%I<WT,4Y&[:[8P.V3T&??K17.:QX1O+[5;B:"6U\F=M^Z=2Q0X4'Y?XO
MNC!R,`GKQ10H4K:R$ZE9-VB3>-KY_(@TJWR9KE@6`],\#\3_`"KH-*L$TS3(
M+1,?NU^8^K=S^=<MHR_VWXMN=2?F*W_U8/Y+^@)^M=K55_<BJ7S?J9X7][.5
M=]=%Z(****YCM"J][96^H6KVUU$)(7QE3['(_6K%%--IW0FDU9F/IOA;1])O
MVO;*S$=RR;#(79CM]!D\5L444.3D[MA&*BK15@HHHI#"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO)/$WQ.UW0O$E_IL=G8O%%
M)B)I%;=MQWPU:TJ4JKM$RK5H45>1ZI>7<%A9S7=U*L4$*%W=CP`*\H^&BRZ]
MXZUKQ(Z%8?F"Y_O.V0/P4?J*IIIOC?XC^6;^XBM=+W`G:P"?@@)+'_>KU?0=
M"LO#FDQ:=8H1&G+,WWG8]6/N:V:C1@XWO)_@<\7+$5(RM:*_%FG1117(=H44
-44`%%%%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
